Contribution · Application — Healthcare

AI for Drug Interaction Checking

Polypharmacy — patients on 5+ drugs — is the norm in elderly and chronic disease care, and interaction lookup is a grind of flipping between databases. LLMs grounded in DrugBank, RxNorm, and CDSCO data can summarize interactions in patient context (age, renal function, other conditions) and flag risks. The rule is strict: grounded generation only, cite the source, and every clinical decision stays with the prescriber.

Application facts

Domain
Healthcare
Subdomain
Pharmacology
Example stack
Claude Opus 4.7 for natural-language explanation · LlamaIndex over DrugBank + RxNorm + CDSCO bulletins · Deterministic interaction engine (e.g., Lexicomp API) as ground truth · Patient context adapter (eGFR, LFT, age, pregnancy) · Clinician UI with severity color-coding and source links

Data & infrastructure needs

  • Licensed pharmacology database (DrugBank, Lexicomp, Micromedex)
  • Patient medication list (FHIR MedicationStatement)
  • Patient lab values for dose adjustment
  • Indian generic name mappings

Risks & considerations

  • Hallucinating interactions that don't exist — or missing real ones
  • Stale database — drug approvals and recalls change weekly
  • Over-alerting causing clinician alert fatigue and ignored warnings
  • Regulatory — CDSCO, FDA, EMA labeling requirements
  • Liability — unclear responsibility if bad advice is acted on

Frequently asked questions

Is AI for drug interaction checking safe?

Only as augmentation over a validated deterministic interaction database. The LLM's role is explaining the interaction in patient context, not discovering new ones. Every output must cite the source database entry, and the clinician is the decision-maker.

What LLM is best for pharmacology?

Any frontier model with strong grounding. Claude Opus 4.7 is well-suited for cautious medical phrasing. The more important choice is your pharmacology data source — prefer licensed, regularly-updated databases over open web.

Regulatory concerns?

India: CDSCO regulates drug safety; Clinical Establishments Act governs decision support tools. US: FDA SaMD (Software as a Medical Device) framework may apply. EU: MDR classifies clinical decision support as medical device from Class IIa. Plan for conformity assessment.

Sources

  1. CDSCO — Central Drugs Standard Control Organization — accessed 2026-04-20
  2. DrugBank — accessed 2026-04-20
  3. RxNorm — NLM — accessed 2026-04-20

Related

  • AI for Clinical Documentation Summarization — Clinical summarization uses LLMs to condense patient records, consult notes, and discharge summaries — a high-value, high-risk application requiring RAG, evaluation, and audit trails.
  • AI for Clinical Trial Patient Matching — Clinical trial matching uses LLMs to parse eligibility criteria against patient records to surface candidates for recruitment — accelerating enrollment while protecting patient privacy and informed consent.
  • AI for Clinical Protocol Generation — Clinical researchers use LLMs to draft protocols from therapeutic area templates, prior studies, and regulator guidance — with formal sponsor and ethics committee review.
  • All Applications — Browse the complete applications library
  • VSET — Programmes offered — B.Tech programs (CSE, AI&ML, AI&DS, Electronics, IIoT)